THE
3002.90.20

Tariff line in 3002.90 — Other types

Blood, antisera, vaccines and immunological products — other: Animal blood prepared for therapeutic, prophylactic or diagnostic uses

$3.8MIndia’s exports in FY 2025-26
31countries bought from India
-5%against FY 2024-25 ($4.0M)
12tonnes shipped in FY 2025-26

India’s exports, year by year

US$, Indian financial years (April–March). Source: DGCI&S, Ministry of Commerce (Tradestat).

Biggest buyers, FY 2025-26

  1. Japan
  2. Germany
  3. Italy
  4. Ireland
  5. Belgium
  6. Oman
  7. Turkey
  8. Switzerland
  9. Argentina
  10. Liberia

Ranked by value. Country-by-country figures are not shown.

GST on this code

0% or 5%

  • 5% — Animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures whether or not modifiedNotification 9/2025-CT(R), Schedule I, entry 231
  • 5% — Animal or Human Blood VaccinesNotification 9/2025-CT(R), Schedule I, entry 232
  • 0% — Human Blood and its componentsNotification 10/2025-CT(R), entry 114

GST on supply within India, as of 1 May 2026. Exports are zero-rated supplies.

Other codes in 3002.90

3002.90.90Blood, antisera, vaccines and immunological products — other types$29M in FY 2025-263002.90.10Blood, antisera, vaccines and immunological products — other: human blood$4.8M in FY 2025-26